Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
BioLineRx Ltd. (BLRX) had Normalized Pre-Tax Income of $-2.59M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.48M |
|
$-1.60M |
|
$0.10M |
|
$0.38M |
|
$3.48M |
|
$-3.00M |
|
$0.42M |
|
$-2.59M |
|
|
Normalized Pre-Tax Income |
$-2.59M |
$-2.59M |
|
$-2.59M |
|
$-2.59M |
|
$-2.59M |
|
$-3.00M |
|
$-2.92M |
|
4.43M |
|
4.43M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$21.58M |
|
$0.15M |
|
$17.21M |
|
$38.80M |
|
$13.62M |
|
$3.36M |
|
$4.34M |
|
$17.96M |
|
$20.84M |
|
$4.49M |
|
$20.84M |
|
4.35M |
|
| Cash Flow Statement Financials | |
$-2.28M |
|
$2.70M |
|
$-1.18M |
|
$3.25M |
|
$2.50M |
|
$-0.75M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.58 |
|
-- |
|
-- |
|
0.14 |
|
0.38 |
|
80.08% |
|
-629.77% |
|
-629.77% |
|
-- |
|
-542.56% |
|
-335.64% |
|
$-2.29M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.04 |
|
0.25 |
|
356.79 |
|
-12.42% |
|
-57.68% |
|
-6.67% |
|
-10.70% |
|
$4.79 |
|
$-0.52 |
|
$-0.51 |
|